Bard Associates Inc. raised its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 349,526 shares of the company’s stock after acquiring an additional 4,474 shares during the period. Bard Associates Inc.’s holdings in Viemed Healthcare were worth $2,803,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. National Bank of Canada FI boosted its holdings in shares of Viemed Healthcare by 91.2% in the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after acquiring an additional 1,596 shares in the last quarter. R Squared Ltd acquired a new stake in Viemed Healthcare in the fourth quarter valued at about $41,000. PDT Partners LLC purchased a new stake in Viemed Healthcare in the 3rd quarter valued at approximately $78,000. Walleye Capital LLC acquired a new position in Viemed Healthcare during the 3rd quarter worth approximately $87,000. Finally, BBR Partners LLC purchased a new position in shares of Viemed Healthcare during the 3rd quarter worth approximately $110,000. 74.24% of the stock is owned by institutional investors and hedge funds.
Viemed Healthcare Stock Down 3.7 %
VMD opened at $7.55 on Tuesday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $10.44. The stock has a market capitalization of $293.97 million, a P/E ratio of 27.96 and a beta of 1.45. The business has a 50 day simple moving average of $8.06 and a 200-day simple moving average of $8.18.
Viemed Healthcare Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Articles
- Five stocks we like better than Viemed Healthcare
- Should You Invest in Penny Stocks?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is the NASDAQ Stock Exchange?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is diluted earnings per share (Diluted EPS)?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report).
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.